SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Resalis Therapeutics Reports RES-010 First-in-Human Safety Data

Resalis Therapeutics announced first-in-human data for RES-010, reporting safety and tolerability. The headline also notes early weight-loss signals.

Story updates

10:01:24 AM UTC
SquawkNews
The completed Phase 1a study data in healthy volunteers showed early signs of pharmacodynamic activi

Related stories